FMC regimen: Difference between revisions

	WikiDoc Resources for FMC regimen
Articles
Most recent articles on FMC regimen Most cited articles on FMC regimen Review articles on FMC regimen Articles on FMC regimen in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on FMC regimen Images of FMC regimen Photos of FMC regimen Podcasts & MP3s on FMC regimen Videos on FMC regimen
Evidence Based Medicine
Cochrane Collaboration on FMC regimen Bandolier on FMC regimen TRIP on FMC regimen
Clinical Trials
Ongoing Trials on FMC regimen at Clinical Trials.gov Trial results on FMC regimen Clinical Trials on FMC regimen at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on FMC regimen NICE Guidance on FMC regimen NHS PRODIGY Guidance FDA on FMC regimen CDC on FMC regimen
Books
Books on FMC regimen
News
FMC regimen in the news Be alerted to news on FMC regimen News trends on FMC regimen
Commentary
Blogs on FMC regimen
Definitions
Definitions of FMC regimen
Patient Resources / Community
Patient resources on FMC regimen Discussion groups on FMC regimen Patient Handouts on FMC regimen Directions to Hospitals Treating FMC regimen Risk calculators and risk factors for FMC regimen
Healthcare Provider Resources
Symptoms of FMC regimen Causes & Risk Factors for FMC regimen Diagnostic studies for FMC regimen Treatment of FMC regimen
Continuing Medical Education (CME)
CME Programs on FMC regimen
International
FMC regimen en Espanol FMC regimen en Francais
Business
FMC regimen in the Marketplace Patents on FMC regimen
Experimental / Informatics
List of terms related to FMC regimen

VisualWikitext

Latest revision as of 16:24, 31 March 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords: FCM regimen

Overview

FMC regimen refers to a regimen consisting of fludarabine, cyclophosphamide and mitoxantrone used in the treatment of resistant or relapsed chronic lymphocytic leukaemia. ^[1]

Regimen

FFludarabine

CCyclophosphamide

MMitoxantrone

Indications

Chronic lymphocytic leukaemia^[1]

References

↑ ^1.0 ^1.1 Bosch F, Ferrer A, López-Guillermo A, Giné E, Bellosillo B, Villamor N; et al. (2002). "Fludarabine, cyclophosphamide and mitoxantrone in the treatment of resistant or relapsed chronic lymphocytic leukaemia". Br J Haematol. 119 (4): 976–84. PMID 12472576.

[pmid12472576-1] 1.0 ^1.1 Bosch F, Ferrer A, López-Guillermo A, Giné E, Bellosillo B, Villamor N; et al. (2002). "Fludarabine, cyclophosphamide and mitoxantrone in the treatment of resistant or relapsed chronic lymphocytic leukaemia". Br J Haematol. 119 (4): 976–84. PMID 12472576.

[1]

@@ Line 2: / Line 2: @@
 {{SI}}
 {{CMG}}; {{AE}} {{AV}}
+{{SK}} FCM regimen
 ==Overview==
 {{PAGENAME}} refers to a regimen consisting of [[fludarabine]], [[cyclophosphamide]] and [[mitoxantrone]] used in the treatment of resistant or relapsed [[chronic lymphocytic leukaemia]].
-.<ref name="pmid12472576">{{cite journal| author=Bosch F, Ferrer A, López-Guillermo A, Giné E, Bellosillo B, Villamor N et al.| title=Fludarabine, cyclophosphamide and mitoxantrone in the treatment of resistant or relapsed chronic lymphocytic leukaemia. | journal=Br J Haematol | year= 2002 | volume= 119 | issue= 4 | pages= 976-84 | pmid=12472576 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12472576  }} </ref>
+<ref name="pmid12472576">{{cite journal| author=Bosch F, Ferrer A, López-Guillermo A, Giné E, Bellosillo B, Villamor N et al.| title=Fludarabine, cyclophosphamide and mitoxantrone in the treatment of resistant or relapsed chronic lymphocytic leukaemia. | journal=Br J Haematol | year= 2002 | volume= 119 | issue= 4 | pages= 976-84 | pmid=12472576 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12472576 }} </ref>
 ==Regimen==